Agenus director granted 2,448 Deferred Stock Units

Agenus Inc. director Timothy Wright received a grant of Deferred Stock Units as part of his board compensation.

Rhea-AI Filing Summary

Agenus Inc. director Timothy Wright received a grant of Deferred Stock Units as part of his board compensation. On April 1, 2026, he acquired 2,448.256 Deferred Stock Units, each tied to one share of Agenus common stock under the company’s Directors' Deferred Compensation Plan.

Following this award, Wright holds a total of 26,361.262 Deferred Stock Units. These units generally convert into the same number of common shares, typically when he ceases to serve as a director. The April 1, 2026 units were valued at $3.319 each, based on the average closing price of Agenus common stock during the prior calendar quarter.

Insider Trade Summary

Grant/Award: 2,448.256 shares

Grant/Award 1 txn

Insider Wright Timothy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	2,448.256	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 26,361.262 contracts (Direct)

Footnotes (3)

1. F1. Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
2. F2. Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
3. F3. $3.319 per Deferred Stock Unit acquired on April 1, 2026. The price of each Deferred Stock Unit acquired on April 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

Key Figures

Deferred Stock Units granted: 2,448.256 units DSU price per unit: $3.319 per unit Total DSUs after grant: 26,361.262 units +1 more

4 metrics

Deferred Stock Units granted 2,448.256 units Grant on April 1, 2026

DSU price per unit $3.319 per unit Average closing price over prior calendar quarter

Total DSUs after grant 26,361.262 units Holdings following April 1, 2026 award

Conversion ratio 1 DSU : 1 share Deferred Stock Units convert into common stock

Key Terms

Deferred Stock Units, Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, Common Stock, average of the closing price

4 terms

Deferred Stock Units financial

"Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan financial

"Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan")."

Common Stock financial

"Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

average of the closing price financial

"The price of each Deferred Stock Unit acquired on April 1, 2026 is the average of the closing price for the Company's common stock"

FAQ

What did Agenus (AGEN) director Timothy Wright report in this Form 4?

Timothy Wright reported receiving 2,448.256 Deferred Stock Units as board compensation. These units are linked one-for-one to Agenus common stock and increase his total Deferred Stock Units holdings to 26,361.262 under the company’s Directors' Deferred Compensation Plan.

How many Deferred Stock Units did Timothy Wright acquire from Agenus (AGEN)?

He acquired 2,448.256 Deferred Stock Units on April 1, 2026. Each unit represents the right to receive one share of Agenus common stock in the future under the company’s Amended and Restated Directors’ Deferred Compensation Plan.

What is the value per Deferred Stock Unit in the Agenus (AGEN) Form 4?

Each Deferred Stock Unit granted on April 1, 2026 was valued at $3.319. This price equals the average closing price of Agenus common stock for all trading days in the calendar quarter immediately before the grant date, as specified by the plan.

When will Timothy Wright’s Agenus (AGEN) Deferred Stock Units be paid out?

The Deferred Stock Units are typically distributed once the director ceases serving on the Agenus board. At that time, each unit converts into one share of common stock under the terms of the Amended and Restated Directors’ Deferred Compensation Plan.

How many Deferred Stock Units does Timothy Wright hold after this Agenus (AGEN) grant?

After the April 1, 2026 award, Timothy Wright holds 26,361.262 Deferred Stock Units. These units are all directly owned and represent the right to receive an equal number of Agenus common shares in the future, subject to plan terms.

Is Timothy Wright’s Agenus (AGEN) Form 4 transaction a market purchase or sale?

No, the Form 4 shows a compensation-related award, not a market trade. The 2,448.256 Deferred Stock Units were acquired as a grant under Agenus’s Directors’ Deferred Compensation Plan, with no open-market buying or selling involved.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Timothy

(Last) (First) (Middle)

C/O AGENUS INC.

3 FORBES ROAD

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGENUS INC [ AGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	04/01/2026		A		2,448.256		(2)	(2)	Common Stock	2,448.256	(3)	26,361.262	D

Explanation of Responses:

1. Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

2. Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

3. $3.319 per Deferred Stock Unit acquired on April 1, 2026. The price of each Deferred Stock Unit acquired on April 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

	/s/Austin Charette as Attorney-in-Fact for Timothy R. Wright	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)